Plain-English translation of NCT05209776 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are trying to better understand arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited heart condition that causes an irregular heartbeat and can be life-threatening. This study collects tiny samples of heart tissue and local blood during a routine electrical mapping procedure to look for inflammation markers that might explain why the disease develops and progresses. By learning more about what triggers inflammation in ARVC, doctors hope to identify new treatment options.
Currently, there are no specific treatments for ARVC, and doctors don't fully understand why inflammation plays such a big role in the disease. Early research suggests inflammation may be a key driver of the condition, but they need to study samples directly from patients' hearts to confirm this and find new ways to help.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll participate as part of your already-scheduled electrical mapping procedure. During this routine heart catheterization, the research team will use a special catheter to collect small samples of heart tissue and local blood from your right ventricle. The study compares samples from people with ARVC to samples from people with healthy hearts undergoing similar procedures, so the additional time and discomfort should be minimal beyond your standard procedure.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
France